Category: HeartWare International Inc.
New Jersey governor Chris Christie's revelation this week that he had LAP-BAND procedure for weight loss hightlights the power of celebrity endorsements for medical procedures
When the New York Post broke the story this week that New Jersey governor and presidential hopeful Chris Christie had underwent weight loss surgery using the LAP-BAND in February some on Wall Street bemoaned the rotund politicians timing.
CardioFocus raises $11 million for its HeartLight endoscopic ablation system in a round of debt financing from Oxford Finance and Silicon Valley Bank.
CardioFocus added $11 million to its coffers in a round of debt financing from Oxford Finance and Silicon Valley Bank as it commercializes its HeartLight endoscopic ablation system overseas and winds up enrollment in a pivotal U.S. trial.
CardioFocus CRO Renny Clark said the funds will help the company prepare for its submission to the FDA for the HeartLight device, which combines an endoscope and a laser ablation device, according to a press release.
Shares HeartWare International surge more than 10% after the medical device company reports 1st-quarter results well above expectations.
Shares of HeartWare International (NSDQ:HTWR) are up by more than 10% today after the heart pump maker skewered expectations with its 1st-quarter results, reporting nearly 87% top-line growth and paring losses by more than ⅓.
Changing expectations affect investors despite unchanged fundamentals: Weaker underlying volumes.
By Stephen Simpson
HeartWare International shares slide 1.3% amid reports of the death of a single patient implanted with the company's recently approved left ventricular assist device.
HeartWare International (NSDQ:HTWR) saw its shares sink 1.3% on Friday, April 5, amid media reports of the death of a patient implanted with the company's left ventricular assist device.
Sales for medical device company HeartWare surged during the 4th quarter and 2012 after the FDA gave the green light to its implanted heart pump last November.
Sales of its implantable heart pump surged during the 4th quarter and 2012 for HeartWare International (NSDQ:HTWR) after the medical device company won FDA approval for its flagship left ventricular assist device late last year.
